| 1 |
28288183 | Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies. | 2017 |
1 |
| 2 |
22004608 | Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers. | 2011 Dec 15 |
9 |
| 3 |
20655304 | Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C. | 2010 Oct 10 |
2 |
| 4 |
20812902 | Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). | 2010 Sep |
1 |
| 5 |
18086804 | Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression. | 2008 Mar |
1 |
| 6 |
18429968 | The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. | 2008 Aug |
1 |
| 7 |
17093006 | Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. | 2007 Feb |
3 |